Now showing items 1-3 of 3
Serum uri acid: neuroprotection in thrombolysis. The Bergen NORSTROKE study
(BioMed Central, 2011-09-25)
Background: A possible synergic role of serum uric acid (SUA) with thrombolytic therapies is controversial and needs further investigations. We therefore evaluated association of admission SUA with clinical improvement ...
Admission C – reactive protein after acute ischemic stroke is associated with stroke severity and mortality: The 'Bergen stroke study'
(BioMed Central, 2009-04-28)
Background: There is growing evidence that inflammation plays an important role in atherogenesis. Previous studies show that C-reactive protein (CRP), an inflammatory marker, is associated with stroke outcomes and future ...
Microemboli-monitoring during the acute phase of ischemic stroke: Is it worth the time?
(BioMed Central, 2010-09-10)
Background The prevalence of microembolic signals (MES) during the acute phase of ischemic stroke and its influence on outcome is not well studied. The aim of our study was to determine the prevalence of MES, the different ...